A single-dose, randomized, cross-over, two-way, open-label study for comparing the absorption of boswellic acids and its lecithin formulation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Phytomedicine, 23.2016, Nr. 12, S. 1375–1382, doi:10.1016/j.phymed.2016.07.009
- Keyword
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2017
- Creator
-
Riva, Antonella
Morazzoni, Paolo
Artaria, Christian
Allegrini, Pietro
Meins, Jürgen
Savio, Daniele
Appendino, Giovanni
Schubert-Zsilavecz, Manfred
Abdel Tawab, Mona
- URN
-
urn:nbn:de:hebis:30:3-441098
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Riva, Antonella
- Morazzoni, Paolo
- Artaria, Christian
- Allegrini, Pietro
- Meins, Jürgen
- Savio, Daniele
- Appendino, Giovanni
- Schubert-Zsilavecz, Manfred
- Abdel Tawab, Mona
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2017
Other Objects (12)
Single-Dose, Randomized, Open-Label, Two-Way, Crossover Bioequivalence Study of Two Formulations of Pregabalin 300 mg Hard Capsules in Healthy Volunteers Under Fasting Conditions
3N-Lecithin und 3N-Lecithin für Diabetiker
Influence of Renal Impairment on the Pharmacokinetics of Afatinib: An Open-Label, Single-Dose Study
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions
Single-Dose, Randomized, Open-Label, Two-Way, Crossover Bioequivalence Study of Two Formulations of Pregabalin 300 mg Hard Capsules in Healthy Volunteers Under Fasting Conditions
3N-Lecithin und 3N-Lecithin für Diabetiker
Influence of Renal Impairment on the Pharmacokinetics of Afatinib: An Open-Label, Single-Dose Study
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions
Single-Dose, Randomized, Open-Label, Two-Way, Crossover Bioequivalence Study of Two Formulations of Pregabalin 300 mg Hard Capsules in Healthy Volunteers Under Fasting Conditions
3N-Lecithin und 3N-Lecithin für Diabetiker
Influence of Renal Impairment on the Pharmacokinetics of Afatinib: An Open-Label, Single-Dose Study
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig
BUER LECITHIN - flüssig